Ensol BioSciences

Ensol Biosciences Inc is a Korean big data-driven biopharmaceutical company. The company is committed to developing drugs for untreatable diseases such as degenerative disc disease, osteoarthritis, cancer, Alzheimer's dementia, and Type 1 diabetes. Its drug portfolio includes Peniel 2000 for degenerative disc disease, Engedi 1000 for osteoarthritis, Charis 1000 for immuno-oncology, Moriah 1000 for Alzheimer’s disease, Shiloah 1000 for Type 1 diabetes, and EAD100 for animal osteoarthritis.